Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma

References

• Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714–720. doi:10.1001/archopht.120.6.714
   PubMedGoogle Scholar
• Miglior S, Zeyen T, Pfeiffer N, et al. Results of the European Glaucoma Prevention Study. Ophthalmology. 2005;112(3):366–375. doi:10.1016/j.ophtha.2004.11.030
   PubMed Web of Science ®Google Scholar
• Raman P, Khy Ching Y, Sivagurunathan PD, Ramli N, Mohd Khalid KH. The Association Between Visual Field Reliability Indices and Cognitive Impairment in Glaucoma Patients. J Glaucoma. 2019;28(8):685–690. doi:10.1097/IJG.0000000000001269
   PubMed Web of Science ®Google Scholar
• La Bruna S, Rai A, Mao G, et al. The OCT RNFL Probability Map and Artifacts Resembling Glaucomatous Damage. Transl Vis Sci Technol. 2022;11(3):18. doi:10.1167/tvst.11.3.18
   PubMed Web of Science ®Google Scholar
• Cordeiro MF, Hill D, Patel R, Corazza P, Maddison J, Younis S. Detecting retinal cell stress and apoptosis with DARC: progression from lab to clinic. Prog Retin Eye Res. 2022;86:100976. doi:10.1016/j.preteyeres.2021.100976
   PubMed Web of Science ®Google Scholar
• Prencipe M, Perossini T, Brancoli G, Perossini M. The photopic negative response (PhNR): measurement approaches and utility in glaucoma. Int Ophthalmol. 2020;40(12):3565–3576. doi:10.1007/s10792-020-01515-0
   PubMed Web of Science ®Google Scholar
• Preische O, Schultz SA, Apel A, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nat Med. 2019;25(2):277–283. doi:10.1038/s41591-018-0304-3
   PubMed Web of Science ®Google Scholar
• Bacioglu M, Maia LF, Preische O, et al. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases. Neuron. 2016;91(1):56–66. doi:10.1016/j.neuron.2016.05.018
   PubMed Web of Science ®Google Scholar
• Mollenhauer B, Dakna M, Kruse N, et al. Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression. Mov Disord. 2020;35(11):1999–2008. doi:10.1002/mds.28206
   PubMed Web of Science ®Google Scholar
• Shahim P, Politis A, van der Merwe A, et al. Neurofilament light as a biomarker in traumatic brain injury. Neurology. 2020;95(6):e610–e622. doi:10.1212/WNL.0000000000009983
   PubMed Web of Science ®Google Scholar
• Kuhle J, Kropshofer H, Haering DA, et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. 2019;92(10):e1007–e1015. doi:10.1212/WNL.0000000000007032
   PubMed Web of Science ®Google Scholar
• Manouchehrinia A, Piehl F, Hillert J, et al. Confounding effect of blood volume and body mass index on blood neurofilament light chain levels. Ann Clin Transl Neurol. 2020;7(1):139–143. doi:10.1002/acn3.50972
   PubMed Web of Science ®Google Scholar
• Vågberg M, Norgren N, Dring A, et al. Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction. PLoS One. 2015;10(8):e0135886. doi:10.1371/journal.pone.0135886
   PubMed Web of Science ®Google Scholar
• Chidlow G, Casson R, Sobrado-Calvo P, Vidal-Sanz M, Osborne NN. Measurement of retinal injury in the rat after optic nerve transection: an RT-PCR study. Mol Vis. 2005;11:387–396.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ederra J, García M, Hicks D, Vecino E. Comparative study of the three neurofilament subunits within pig and human retinal ganglion cells. Mol Vis. 2004;10:83–92.
   PubMed Web of Science ®Google Scholar
• Roh M, Zhang Y, Murakami Y, et al. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One. 2012;7(7):e40065. doi:10.1371/journal.pone.0040065
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Shimazawa M, Hara H. Alterations in neurofilament light in optic nerve in rat kainate and monkey ocular hypertension models. Brain Res. 2004;1013(2):241–248. doi:10.1016/j.brainres.2004.04.023
   PubMed Web of Science ®Google Scholar
• Yuan A, Nixon RA. Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies. Front Neurosci. 2021;15:689938. doi:10.3389/fnins.2021.689938
   PubMed Web of Science ®Google Scholar
• Champely S Pwr: basic Functions for Power Analysis; 2020. Available from: https://CRAN.R-project.org/package=pwr. Accessed July 21, 2023.
   Google Scholar
• Shabihkhani M, Lucey GM, Wei B, et al. The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings. Clin Biochem. 2014;47(4–5):258–266. doi:10.1016/j.clinbiochem.2014.01.002
   PubMed Web of Science ®Google Scholar
• Rissin DM, Kan CW, Campbell TG, et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol. 2010;28(6):595–599. doi:10.1038/nbt.1641
   PubMed Web of Science ®Google Scholar
• Comacchio F, Mariotto S, Neri E, et al. Neurofilament light chain: a novel biomarker in patients with glaucoma. Invest Ophthalmol Vis Sci. 2020;61(7):246.
   Google Scholar
• Woltsche N, Valentin K, Hoeflechner L, et al. Neurofilament light chain: a new marker for neuronal decay in the anterior chamber fluid of patients with glaucoma. Br J Ophthalmol. 2022. doi:10.1136/bjo-2021-320828
   PubMed Web of Science ®Google Scholar
• Wu Z, Medeiros FA. Sample Size Requirements of Glaucoma Clinical Trials When Using Combined Optical Coherence Tomography and Visual Field Endpoints. Sci Rep. 2019;9(1):18886. doi:10.1038/s41598-019-55345-x
   PubMedGoogle Scholar
• Montesano G, Quigley HA, Crabb DP. Improving the Power of Glaucoma Neuroprotection Trials Using Existing Visual Field Data. Am J Ophthalmol. 2021;229:127–136. doi:10.1016/j.ajo.2021.04.008
   PubMed Web of Science ®Google Scholar